You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Blood and bone marrow cancers

Selinexor with dexamethasone for treating relapsed or refractory multiple myeloma after 4 or more treatments

  • Technology appraisal guidance
  • Reference number: TA970
  • Published:  08 May 2024
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

On this page

  1. Implementation support
  2. Guidance into practice

Tools and resources

Tools to help you put the guidance into practice.

Implementation support

  • Resource impact template (Excel 983 KB)

    Published:
    08 May 2024
  • Resource impact report (Word 59 KB)

    Published:
    08 May 2024

Guidance into practice

  • About the Into practice guide

  • Practical steps to improving the quality of care and services using NICE guidance

Back to top